Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46

1.

The chaos of hypertension guidelines for chronic kidney disease patients.

Castillo-Rodriguez E, Fernandez-Fernandez B, Alegre-Bellassai R, Kanbay M, Ortiz A.

Clin Kidney J. 2019 Sep 28;12(6):771-777. doi: 10.1093/ckj/sfz126. eCollection 2019 Dec.

2.

Design and optimization strategies for the development of new drugs that treat chronic kidney disease.

Ramos AM, Fernández-Fernández B, Pérez-Gómez MV, Carriazo Julio SM, Sanchez-Niño MD, Sanz A, Ruiz-Ortega M, Ortiz A.

Expert Opin Drug Discov. 2020 Jan;15(1):101-115. doi: 10.1080/17460441.2020.1690450. Epub 2019 Nov 18.

PMID:
31736379
3.

[Gender is not in genes].

Fernández-Rodríguez M, Villaverde-González A, Fernández-Fernández B.

Rev Int Androl. 2019 Oct - Dec;17(4):119-122. doi: 10.1016/j.androl.2019.04.005. Epub 2019 Aug 30. Spanish. No abstract available.

PMID:
31477482
4.

Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

Fernandez-Fernandez B, Fernandez-Prado R, Górriz JL, Martinez-Castelao A, Navarro-González JF, Porrini E, Soler MJ, Ortiz A.

Clin Kidney J. 2019 May 31;12(3):313-321. doi: 10.1093/ckj/sfz070. eCollection 2019 Jun.

5.

MAP3K kinases and kidney injury.

Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, Fernandez-Fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-Niño MD.

Nefrologia. 2019 Nov - Dec;39(6):568-580. doi: 10.1016/j.nefro.2019.03.004. Epub 2019 Jun 10. Review. English, Spanish.

6.

Clarifying the concept of chronic kidney disease for non-nephrologists.

Perez-Gomez MV, Bartsch LA, Castillo-Rodriguez E, Fernandez-Prado R, Fernandez-Fernandez B, Martin-Cleary C, Gracia-Iguacel C, Ortiz A.

Clin Kidney J. 2019 Feb 14;12(2):258-261. doi: 10.1093/ckj/sfz007. eCollection 2019 Apr.

7.

Working towards novel albuminuria endpoints in chronic kidney disease.

Fernandez-Fernandez B, Sanchez-Niño MD, Ortiz A.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):80-82. doi: 10.1016/S2213-8587(18)30352-8. Epub 2019 Jan 8. No abstract available.

PMID:
30635227
8.

Advances in understanding the role of angiotensin-regulated proteins in kidney diseases.

Sanz AB, Ramos AM, Soler MJ, Sanchez-Niño MD, Fernandez-Fernandez B, Perez-Gomez MV, Ortega MR, Alvarez-Llamas G, Ortiz A.

Expert Rev Proteomics. 2019 Jan;16(1):77-92. doi: 10.1080/14789450.2018.1545577. Epub 2018 Nov 27.

PMID:
30412432
9.

Research update for articles published in EJCI in 2016.

Adlbrecht C, Blanco-Verea A, Bouzas-Mosquera MC, Brion M, Burtscher M, Carbone F, Chang TT, Charmandari E, Chen JW, Correia-Costa L, Dullaart RPF, Eleftheriades M, Fernandez-Fernandez B, Goliasch G, Gremmel T, Groeneveld ME, Henrique A, Huelsmann M, Jung C, Lichtenauer M, Montecucco F, Nicolaides NC, Niessner A, Palmeira C, Pirklbauer M, Sanchez-Niño MD, Sotiriadis A, Sousa T, Sulzgruber P, van Beek AP, Veronese N, Winter MP, Yeung KK, Bouzas-Mosquera A.

Eur J Clin Invest. 2018 Oct;48(10):e13016. doi: 10.1111/eci.13016. Epub 2018 Sep 16. Review. No abstract available.

PMID:
30099749
10.

Meso-American nephropathy: what we have learned about the potential genetic influence on chronic kidney disease development.

Perez-Gomez MV, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A.

Clin Kidney J. 2018 Aug;11(4):491-495. doi: 10.1093/ckj/sfy070. Epub 2018 Jul 31.

11.

Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.

Castillo-Rodriguez E, Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Fernandez-Fernandez B, Kanbay M, Tejedor A, Lazaro A, Ruiz-Ortega M, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD.

Toxins (Basel). 2018 Jul 19;10(7). pii: E300. doi: 10.3390/toxins10070300. Review.

12.

Albumin downregulates Klotho in tubular cells.

Fernandez-Fernandez B, Izquierdo MC, Valiño-Rivas L, Nastou D, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1712-1722. doi: 10.1093/ndt/gfx376.

PMID:
29425318
13.

Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men.

Fernandez-Prado R, Fernandez-Fernandez B, Ortiz A.

Clin Kidney J. 2018 Feb;11(1):1-6. doi: 10.1093/ckj/sfx154. Epub 2018 Feb 6.

14.

Paricalcitol and albuminuria: tread carefully.

Fernandez-Fernandez B, Ortiz A.

Lancet Diabetes Endocrinol. 2018 Jan;6(1):3-5. doi: 10.1016/S2213-8587(17)30361-3. Epub 2017 Nov 2. No abstract available.

PMID:
29104157
15.

Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase.

Sanchez-Niño MD, Sanz AB, Ramos AM, Fernandez-Fernandez B, Ortiz A.

Clin Kidney J. 2017 Apr;10(2):188-191. doi: 10.1093/ckj/sfx023. Epub 2017 Mar 31.

16.

Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".

Castillo-Rodríguez E, Pizarro-Sánchez S, Sanz AB, Ramos AM, Sanchez-Niño MD, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A.

Toxins (Basel). 2017 Mar 23;9(4). pii: E114. doi: 10.3390/toxins9040114. Review.

17.

2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications.

González N, Prieto I, Del Puerto-Nevado L, Portal-Nuñez S, Ardura JA, Corton M, Fernández-Fernández B, Aguilera O, Gomez-Guerrero C, Mas S, Moreno JA, Ruiz-Ortega M, Sanz AB, Sanchez-Niño MD, Rojo F, Vivanco F, Esbrit P, Ayuso C, Alvarez-Llamas G, Egido J, García-Foncillas J, Ortiz A; DiabetesCancerConnect Consortium.

Oncotarget. 2017 Mar 14;8(11):18456-18485. doi: 10.18632/oncotarget.14472. Review.

18.

Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.

Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, Pizarro-Sánchez MS, Sanchez-Niño MD, Sanz AB, Fernandez-Fernandez B, Ortiz A.

Nephron. 2017;136(4):263-267. doi: 10.1159/000447649. Epub 2016 Oct 22. Review.

19.

Circulating CXCL16 in Diabetic Kidney Disease.

Elewa U, Sanchez-Niño MD, Mahillo-Fernández I, Martin-Cleary C, Belen Sanz A, Perez-Gomez MV, Fernandez-Fernandez B, Ortiz A.

Kidney Blood Press Res. 2016;41(5):663-671. Epub 2016 Sep 26.

20.

MXRA5 is a TGF-β1-regulated human protein with anti-inflammatory and anti-fibrotic properties.

Poveda J, Sanz AB, Fernandez-Fernandez B, Carrasco S, Ruiz-Ortega M, Cannata-Ortiz P, Ortiz A, Sanchez-Niño MD.

J Cell Mol Med. 2017 Jan;21(1):154-164. doi: 10.1111/jcmm.12953. Epub 2016 Sep 6.

Supplemental Content

Loading ...
Support Center